Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 19/20 | 0.72 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.69 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.69 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.69 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.53 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.53 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7279924 | 0.99 | PDE5A (0.73) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7279986 | 0.98 | PDE5A (0.72) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7279975 | 0.90 | PDE5A (0.69) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7410322 | 0.90 | PDE5A (0.69) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7439211 | 0.89 | PDE5A (0.72) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| Hydrochloric Acid SCHEMBL7433884 | 0.89 | PDE5A (0.70) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7406311 | 0.86 | PDE5A (0.66) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7278185 | 0.85 | PDE5A (0.78) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7279930 | 0.84 | PDE5A (0.76) | PDE5ATBXAS1PDE3BPDE3APTGS1 | |
| SCHEMBL7437411 | 0.84 | PDE5A (0.69) | PDE5ATBXAS1PDE3BPDE3APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0579496-B1 | 4-Aminoquinazoline derivatives, and their use as medicine | ONO PHARMACEUTICAL CO (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-5439895-A | Cardiovascular disorders; inhibitor of thromboxane A2 synthetase and cyclic guanosine 3',5'-monophosphate | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-08-08 | — | — | US | disclosed |
| US-5436233-A | Nervous system disorders | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| EP-0579496-A1 | 4-Aminoquinazoline derivatives, and their use as medicine | ONO PHARMACEUTICAL CO., LTD. (JP) | 1994-01-19 | — | — | EP | disclosed |